Pd - Open Access .click

Results 31 to 40 of about 1,895,251 (293)

DataSheet1_Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework.pdf

, 2022
While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source

Image5_Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework.PNG

, 2022
While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source

Zhejiang dianli
The study of effective feature extraction and optimization algorithms is crucial for improving the accuracy of partial discharge （PD） detection in gas-insulated switchgear （GIS）. To enhance the precision and reliability of GIS partial discharge detection
CHEN Xiaoxin +6 more
doaj +1 more source

Using the Palladium as core and Platinum as shell for ORR [PDF]

Hydrogen, Fuel Cell & Energy Storage, 2014
In this work, electrocatalyst with core-shell structure (Pd as core and Pt as shell on VulcanXC-72R) was synthesis. Not only this structure can reduce the amount of platinum but it also can increase the gas diffusion electrode (GDE) performance in ...
Masoumeh Javaheri
doaj +1 more source

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade

Oncotarget, 2017
Immune checkpoint blockades, such as inhibitors against programmed death 1 (PD-1) and its ligand (PD-L1), have received extensive attention in the past decade because of their dramatic clinical outcomes in advanced malignancies. However, both primary and acquired resistance becomes one of the major obstacles, which greatly limits the long-lasting ...
Bai, Jie +5 more
openaire +3 more sources

Image1_Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework.PNG

, 2022
While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source

D-glucose catalytic oxidation over palladium nanoparticles introduced in the hypercrosslinked polystyrene matrix

Green Processing and Synthesis, 2013
This paper reports palladium (Pd)-containing nanoparticle (NP) formation in nanoporous hypercrosslinked polystyrene (HPS), using Pd acetate as a precursor.
Doluda Valentin Y. +9 more
doaj +1 more source

A proposed benchmark model using a modularised approach to calculate IFRS 9 expected credit loss

Cogent Economics & Finance, 2020
The objective of this paper is to develop a methodology to calculate expected credit loss (ECL) using a transparent-modularised approach utilising three components: probability of default (PD), loss given default (LGD) and exposure at default (EAD).
Willem Daniel Schutte +4 more
doaj +1 more source

Inside PD-1/PD-L1,2 with their inhibitors

European Journal of Medicinal Chemistry, 2023
This review summarizes current knowledge in the development of immune checkpoint inhibitors, including antibodies and small molecules.
Boisgerault, Nicolas, Bertrand, Philippe
openaire +2 more sources

Image3_Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework.png

, 2022
While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source

pt